Gestational Diabetes Market Size
Market Size in USD Bn
CAGR9.1%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 9.1% |
| Market Concentration | Medium |
| Major Players | Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Merck & Co., Inc., F. Hoffmann-La Roche Ltd and Among Others |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Gestational Diabetes Market Analysis
The gestational diabetes market is estimated to be valued at USD 10.26 Bn in 2025 and is expected to reach USD 18.88 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.1% from 2025 to 2032. An increasing number of risk factors associated with gestational diabetes such as rising obesity levels, older maternal age during pregnancy and sedentary lifestyles are contributing to the rising disease incidence. However, the lack of symptoms in early stages of gestational diabetes remains a major challenge.